Downregulation hsa_circ_0006620 inhibit the malignant progression of prostate cancer by regulation miR-502-3p/HK2 axis mediated aerobic glycolysis

Author:

Li Xue1,Wang Menghan1,Luo Yulin1,Huang Qingqing1,Huang Gang1,Jin Mingming2

Affiliation:

1. Shanghai Key Laboratory of Molecular Imaging

2. Shanghai University of Medicine and Health Sciences

Abstract

Abstract Background: Circular RNAs (circRNA) are a class of covalently closed single-stranded RNAs that have been implicated in cancer progression by regulation metabolism. But, the circRNA roles in prostate cancer remains unknown. Methods: This research aimed to use FISH and RT-qPCR to investigate hsa_circ_0006620 expression in prostate cancer cells and tissues after high-throughput sequencing. Our team made the luciferase reporter assay to validate hsa_circ_0006620 downstream target. Transwell migration assay, 5-ethynyl-20-deoxyuridine, and cell counting kit-8 were applied to investigate both proliferation and migration. In vivo tumorigenesis and metastasis assays were performed to investigate the hsa_circ_0006620 role in prostate cancer. Results: The outputs elucidated that hsa_circ_0006620 expression incremented in prostate cancer cells and tissues. Hsa_circ_0006620 downregulation inhibited prostate cancer cell proliferation as well as migration in in vivo and in vitro experiments. The luciferase results validated that miR-502-3p and HK2 were hsa_circ_0006620 downstream targets. HK2 overexpression or miR-502-3p inhibition reversed prostate cancer cell migration after hsa_circ_0006620 silencing. The study also found that overexpression of HK2 or inhibition of prostate cancerreversed aerobic glycolysis after hsa_circ_0006620silencing. Conclusion: Results demonstrate that hsa_circ_0006620 downregulation inhibits prostate cancer malignant progression by regulation miR-502-3p/HK2 axis mediated aerobic glycolysis.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3